IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding IGC Pharma, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 29 | 29 | 0 |
| Shares | 4.18M | 3.27M | −910.5K (−21.8%) |
| Value | $3.97M | $1.73M | −$2.24M (−56.3%) |
New holders (4)
Institutions that held IGC Pharma, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 217,749 | $115.0K | 0.00% |
| Commonwealth Equity Services, LLC | 50,250 | $26.0K | 0.00% |
| HRT Financial LP | 19,694 | $10.0K | 0.00% |
| ExodusPoint Capital Management, LP | 13,049 | $7.00K | 0.00% |
Sold out (4)
Institutions that held IGC Pharma, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 1,377,257 | $1.31M |
| Two Sigma Securities, LLC | 14,436 | $14.0K |
| Tower Research Capital LLC (TRC) | 1,364 | $1.00K |
| Fairfield Financial Advisors, LTD | 500 | $474 |